GCS Resources - Page 3 of 4 - The GCS Project
Patient/Advocate Diane Redington and Dr. Whitfield Growden discuss genomic analysis, patterns of resistance, and immunotherapy. This is part five of a nine-part series. Dr. Growden discusses tumor specimens used for genomic analysis and the impact of tumor changes. Recognizing patterns of resistance is very important for treatment. Also discussed is a type of immunotherapy called […]
Posted: April 27, 2017 | View More »
Patient/advocate Diane Redington and Dr. Whitfield Growden discuss the management of ovarian and uterine carcinosarcoma. This is part four of a nine-part series. Dr. Growden discusses important differences between ovarian and uterine carcinosarcoma and takes us through the stages and treatment modalities for each at the various stages. Chemotherapy, including intraperitoneal chemotherapy, and radiation is […]
Posted: April 24, 2017 | View More »
Patient/advocate Diane Redington and Dr. Whitfield Growden discuss current scientific findings and clinical trials in ovarian and uterine carcinosarcoma. This is part three of a nine-part series. Dr. Growden discusses how they have examined tumors (from Mass General’s tumor bank) of the ovary, uterus, fallopian tubes, and vagina. They found approximately 150 different mutations and […]
Posted: April 20, 2017 | View More »
Patient/advocate, Diane Redington and Dr. Michael Birrer discuss the results of GCS Project research to-date and where the research is headed. This is part two of a nine-part series. Dr. Birrer discusses the fact that doctors typically treat ovarian carcinosarcoma the same as ovarian cancer, but they are NOT the same, and they should not […]
Posted: April 18, 2017 | View More »
Patient/advocate, Diane Redington, and Dr. Michael Birrer discuss the results of GCS Project research to-date and where the research is headed. This is part one of a nine-part series. Dr. Birrer states that they have already had initial results. They are doing what Dr. Birrer calls a “molecular deep dive”—a technically sophisticated analysis—on a fairly […]
Posted: April 17, 2017 | View More »
Part 2—Diane’s story update, March 2017: It will soon be 2 years since I was was diagnosed with carcinosarcoma (April 2015). I wanted to provide an update of where I am and what is going on with the GCS Project. Clinically, I am pretty much the same. I am under the care of […]
Posted: March 20, 2017 | View More »
The second of two interviews conducted on January 5, 2017, with Diane Redington and Dr. Growdon on the topic of carcinosarcoma. This interview discusses: genomic analysis of carcinosarcoma, patterns of resistance, immunotherapy and clinical trials.
Posted: March 17, 2017 | View More »
The following transcript is from an interview between Dr. Whitfield Growdon (MDC), a leading GYN Oncological Surgeon from Mass General Cancer Center in Boston and Diane Redington (DR), a woman with a Gynecological Carcinosarcoma (GCS) who is seeking to motivate researchers to advance the science and uncover knowledge about carcinosarcoma and find a cure for this cancer. This interview discusses diagnosis and treatment of MMMT.
Posted: March 9, 2017 | View More »
An interview with Dr. Marcela del Carmen, leading GYN Oncologist, on the topic of GYN carcinosarcoma (also known MMMT) discussing diagnosis and treatment.
Posted: February 5, 2017 | View More »
An interview with Dr. Birrer, leading researcher, on emerging immunotherapies with Gynecologic Carcinosarcoma cancer (MMMT).
Posted: January 16, 2017 | View More »